Skip to main content

Diabetes

  • Retractable Technologies, Smart Meter win DSN/ECRM Buyers Choice Awards

    OAK BROOK, Ill. — Retractable Technologies earlier this month won the Drug Store News/ECRM Buyers’ Choice Award for its VanishPoint syringes, blood collection products, and IV catheters during the recent ECRM Diabetes/Clinical Programs, Chronic Care Management & Adherence Solutions EPPS, held here.

    The finalist was Smart Meter for its iGlucose Diabetes Solution.

  • OneTouch research finds combination of BGM, diabetes app most effective

    CHESTERBROOK, Pa. — New research published in two leading diabetes journals demonstrated accuracy and reliability of the OneTouch Verio Flex blood glucose monitoring system, and when the system was used with the OneTouch Reveal mobile app, it was associated with significant improvements in glycemic control.  

    In a study just published in the Journal of Diabetes Science and Technology, leading experts in self-monitoring of blood glucose found that the "new system showed a high level of measurement accuracy."

  • FDA approves new Bydureon formulation, auto-injector

    SILVER SPRING, Md. — The Food and Drug Administration has approved an auto-injector and new formulation of a once-weekly treatment for Type 2 diabetes from AstraZeneca. Bydureon BCise offers a single-dose auto-injector for adults with Type 2 diabetes whose blood sugar is uncontrolled on one or more oral medicines.

  • Lilly launches Humalog Junior KwikPen

    INDIANAPOLIS — Eli Lilly’s latest introduction is making half-unit doses of insulin easier for patients with Type 1 and Type 2 diabetes. The company on Wednesday launched its Humalog Junior KwikPen, which it said is the only prefilled, disposable half-unit insulin pen. The Food and Drug Administration approved the product in June to treat diabetes.

  • FDA approves Novo Nordisk’s Fiasp fast-acting insulin

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new fast-acting mealtime insulin from Novo Nordisk. The agency granted approval to Fiasp to treat adults with diabetes.

    The drug is a formulation featuring the company’s NovoLog insulin aspart developed with the aim of achieving properties that more closely match the natural physiological insulin mealtime response of someone without diabetes.

  • Thrifty White Pharmacy is improving patient outcomes through new diabetes pilot

    PLYMOUTH, Minn. — Thrifty White Pharmacy is making a significant difference in patient lives through its new diabetes care program, which places recipients into a medsync program replete with comprehensive medication therapy management sessions, patient disease management goal setting and follow through. Thrifty White also offers a compliance packaging service, HealthyPack Rx, that helps organize and manage a patient's medication.

  • BD intros 6-mm pen needle for injection pens

    FRANKLIN LAKES, N.J. — BD is bringing a new option for patients using pen injection devices. The BD Ultra-Fine micro pen needle 6 mm x 32 gauge is set for distribution in September, bringing a new needle length option to patients with diabetes who inject insulin.

  • Ascensia fosters product innovation through new Ascensia Diabetes Challenge

    LISBON, Portugal — Ascensia Diabetes Care on Wednesday announced the launch of the Ascensia Diabetes Challenge, a global innovation competition that is seeking innovative digital solutions to support diabetes management and improve the lives of those living with type 2 diabetes.

X
This ad will auto-close in 10 seconds